mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.4 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.4 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |